Acasti Pharma (ACST) Insider Trading & Ownership

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

$3.17

-0.18 (-5.37%)

(As of 04/17/2024 ET)

Current Insider Ownership Percentage: 13.51%
Number Of Insiders Buying (Last 12 Months): 2
Amount Of Insider Buying (Last 12 Months): $1.25 M
Number Of Insiders Selling (Last 12 Months): 0

Get ACST Insider Trade Alerts

Want to know when executives and insiders are buying or selling Acasti Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ACST Insider Buying and Selling by Quarter

Ad Paradigm Press

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

Acasti Pharma Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
9/25/2023	Vimal Kavuru	Director	Buy	676,371	$1.85	$1,251,286.35
8/31/2023	Donald Olds	Director	Buy	381	$2.05	$781.05

(Data available from 1/1/2013 forward)

ACST Insider Trading Activity - Frequently Asked Questions

Who is on Acasti Pharma's Insider Roster?: The list of insiders at Acasti Pharma includes Donald Olds, and Vimal Kavuru. Learn more on insiders at ACST.
What percentage of Acasti Pharma stock is owned by insiders?: 13.51% of Acasti Pharma stock is owned by insiders. Learn more on ACST's insider holdings.

Which Acasti Pharma insiders have been buying company stock?: The following insiders have purchased ACST shares in the last 24 months: Donald Olds ($781.05), and Vimal Kavuru ($1,251,286.35).
How much insider buying is happening at Acasti Pharma?: Insiders have purchased a total of 676,752 ACST shares in the last 24 months for a total of $1,252,067.40 bought.

More Insider Trading Tools from MarketBeat

Related Companies:

Insider Tracking Tools:

Insider Trading By Country:

Latest Articles:

This page (NASDAQ:ACST) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Acasti Pharma (ACST) Insider Trading & Ownership

ACST Insider Buying and Selling by Quarter

Acasti Pharma Insider and Congressional Trades History

ACST Insider Trading Activity - Frequently Asked Questions

More Insider Trading Tools from MarketBeat

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Acasti Pharma (ACST) Insider Trading & Ownership

Acasti Pharma (NASDAQ:ACST) Insider Buying and Selling Activity

ACST Insider Buying and Selling by Quarter

Acasti Pharma Insider and Congressional Trades History

ACST Insider Trading Activity - Frequently Asked Questions

More Insider Trading Tools from MarketBeat